Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals.

Mak, Willem A; Koeleman, Johannes G M; Ong, David S Y

Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals.

Mak, Willem A; Koeleman, Johannes G M; Ong, David S Y.

Mak WA; Department of Medical Microbiology and Infection Control, Franciscus Gasthuis en Vlietland, Rotterdam, the Netherlands. Electronic address: ashwinmak98@gmail.com.
Koeleman JGM; Department of Medical Microbiology and Infection Control, Franciscus Gasthuis en Vlietland, Rotterdam, the Netherlands.
Ong DSY; Department of Medical Microbiology and Infection Control, Franciscus Gasthuis en Vlietland, Rotterdam, the Netherlands; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

J Clin Virol ; 150-151: 105158, 2022 06.

Article in English | MEDLINE | ID: covidwho-1783471

Subject(s)

COVID-19; SARS-CoV-2; Antibodies, Viral; Enzyme-Linked Immunospot Assay; Humans; T-Lymphocytes

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: J Clin Virol Journal subject: Virology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google